Cargando…
Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-α inhibitor
Biologics has been widely used in the treatment of rheumatoid arthritis. We aimed to determine whether etanercept, a TNF-α inhibitor (TNFi) that is used to treat patients with rheumatoid arthritis (RA), affects cancer risk. This retrospective matched cohort study used data in the Registry of Catastr...
Autores principales: | Lan, Joung-Liang, Tseng, Chun-Hung, Chen, Jiunn-Horng, Cheng, Chi-Fung, Liang, Wen-Miin, Tsay, Gregory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319502/ https://www.ncbi.nlm.nih.gov/pubmed/28207513 http://dx.doi.org/10.1097/MD.0000000000006055 |
Ejemplares similares
-
Cost-effectiveness analysis of etanercept plus methotrexate vs triple therapy in treating Chinese rheumatoid arthritis patients
por: Shi, Zhi-Chao, et al.
Publicado: (2020) -
A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients
por: Tian, Feng, et al.
Publicado: (2019) -
Association Between Anti-TNF Therapy for Rheumatoid Arthritis and Hypertension: A Meta-Analysis of Randomized Controlled Trials
por: Zhao, Qingwei, et al.
Publicado: (2015) -
Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis
por: Yu, Kuang-Hui, et al.
Publicado: (2022) -
Hypothyroidism risk associated with rheumatoid arthritis: A population-based retrospective cohort study
por: Huang, Chung-Ming, et al.
Publicado: (2022)